Review



glauser 2013a  (Glauser Life Sciences Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Glauser Life Sciences Inc glauser 2013a
    Glauser 2013a, supplied by Glauser Life Sciences Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/glauser+2013a/glauser+2013a/10__1002_slash_14651858__cd003032__pub5-419-33-39
    Average 90 stars, based on 1 article reviews
    glauser 2013a - by Bioz Stars, 2026-10
    90/100 stars

    Images

    Related Articles

    other:

    Article Title: Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents
    Article Snippet: Shinnar 2017 Provides further data on the study ( Glauser 2013a ), previously included; these data are irrelevant to the aims of this review.

    Article Title: Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents
    Article Snippet: Cochrane Database of Systematic Reviews Allocation Only two of the studies described explicitly the methods of allocation concealment (Coppola 2004; Glauser 2013a).

    Article Title: Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents
    Article Snippet: Glauser 2013a (Continued) AS: absence seizure EEG: electroencephalogram ESM: ethosuximide LTG: lamotrigine PCB: placebo VPA: valproic acid VPS: sodium valproate Characteristics of excluded studies [ordered by study ID] Study Reason for exclusion Archives of Disease in Childhood 2010 A commentary relating to Glauser 2013a.

    Article Title: Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents
    Article Snippet: Open in a separate window AS: absence seizure EEG: electroencephalogram ESM: ethosuximide LTG: lamotrigine PCB: placebo VPA: valproic acid VPS: sodium valproate Glauser 2013a Characteristics of excluded studies [ordered by study ID] Study Reason for exclusion Besag 1995 No randomisation.

    Article Title: Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents
    Article Snippet: Glauser 2017 Provides further data on the study (Glauser 2013a), previously included; these data are irrelevant to the aims of this review.

    Article Title: Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents
    Article Snippet: Glauser 2013a {published data only} Glauser TA, Cnaan A, Shinnar S, Hirtz DG, Dlugos D, Masur D, et al, Childhood Absence Epilepsy Study Team.

    Article Title: Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents
    Article Snippet: Glauser 2013a {published data only} Glauser TA, Cnaan A, Shinnar S, Hirtz DG, Dlugos D, Masur D, et al. Childhood Absence Epilepsy Study Team.

    Article Title: Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents
    Article Snippet: Three of the included studies (Callaghan 1982; Sato 1982; Martinovic 1983) date back 30 years and there was an obvious diIerence in the quality of the reporting in comparison with the newer studies (Frank 1999; Coppola 2004; Huang 2009; Glauser 2013a).



    Similar Products

    glauser 2013a  (Glauser Life Sciences Inc)
    90
    Glauser Life Sciences Inc glauser 2013a
    Glauser 2013a, supplied by Glauser Life Sciences Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/glauser+2013a/glauser+2013a/10__1002_slash_14651858__cd003032__pub5-419-33-39
    Average 90 stars, based on 1 article reviews
    glauser 2013a - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier

    Image Search Results